Loading clinical trials...
Loading clinical trials...
Copenhagen Menopause Study (COMPASS): A Randomized Clinical Trial
Conditions
Interventions
Triptorelin 11.25 mg
Sodium Chloride 0.9%
+3 more
Locations
1
Denmark
Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Copenhagen University Hospital Herlev.
Herlev, Denmark
Start Date
October 2, 2025
Primary Completion Date
December 1, 2027
Completion Date
May 1, 2028
Last Updated
March 2, 2026
NCT06767150
NCT05571514
NCT05902078
NCT05010590
NCT07329543
NCT05332626
Lead Sponsor
Martin Blomberg Jensen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions